The authors compared tigecycline 100mg intravenously (iv) followed by 50mg every 12h and ... 12.2% of the non-VAP and 19.1% of the VAP patients died, whereas 12.5% and 12.3% of non-VAP and VAP ...
Some results have been hidden because they may be inaccessible to you